• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/58

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

58 Cards in this Set

  • Front
  • Back
  • 3rd side (hint)

CIN-I

few atypia


Cytoplasmic holos in lower epithelial cells

CIN-II

Progressive atypia


Immature cell above lower third

CIN-III

Diffuse atypia


loss of maturation


Immature basal cells upto epithelial surface

LSILs Characteristics

Productive HPV infection


No disruption of cell cycle


Regresses spontaneously

HSILs Characteristics

Cell cycle deregulation


Non productive HPV infection


Progresses to invasive carcinoma

Stage 0

Carcinoma in situ

Stage I

Carcinoma confined to the cervix

Stage Ia

Preclinical carcinoma


Diagnosis only by microscope

Stage Ia1

Stromal invasion


No greater than 3mm


No wider than 7mm



Stage Ia1

Microinvasive carcinoma

Stage Ia2

Maximum depth of invasion greater than 3 mm,width not more than 7mm

Stage Ib

Greater than Ia2

Maximum depth of invasion greater than 3 mm,width not more than 7mm

Stage II

Extends beyond the cervix but not to the pelvic wall.


Involves the vagina but not the lower third


Stage III

Extends onto pelvic wall


Involves the lower third

Stage IV

Extends beyond true pelvis

Risk factors for CIN

1. High risk HPV 16 or 18


2. Multiple sexual partners


3. Young age at first intercourse

Low risk HPV

Type 6,11

High risk HPV

Type 16 and 18 and above

High risk HPV pathogenesis

E6,E7 > suppression of p53 and RB >


Carcinoma in situ

Peak incidence of cervical carcinoma

45 years in women

Morphology of SCC

Nests of malignant squamous epithelium keratinized or non keratinized

Diagnosis of CIN

1. Visual inspection by acetic acid


2. Cytological screening PAP test


3. Cervical biopsy and histopathology


4. HPV DNA testing


5. Colposcopy when PAP test is abnormal

5 tests

PAP smear

Cytological preparation of exfoliated cellls

PAP smear stained

Stained with Papanicolaou method

Schedule for PAP test

First smear at 21 years or within 3 years of onset of sexual activity then annually.


After age 30 with 3 consecutive normal results test in every 2 or 3 years

Papanicolaou grading

Group I normal


Group II atypical cell not malignant


Group III suspension of malignancy


Group IV few malignant cells


Group V large number of malignant cells

Endometriosis

Presence of ectopic endometrial tissue outside the uterus

Sites of endometriosis

Ovaries


Uterine ligaments


Rectovaginal septum


Laparotomy scars


Cul de sac


Pelvic peritoneum


Intestine


Appendix


Mucosa of cervix Vagina Felopian tube

Endometriosis age group

Age groups in active reproductive life,most often in 3rd and 4th decades

Pathogenesis of endometriosis

Regurgitation theory


Benign metastasis theory


Metaplastic theory


Progenitor cell theory

Regurgitation theory

Retrograde mensuration

Clinical features of endometriosis

Severe dysmenorrhoea


Dysperunia


Pelvic pain


Pain on defecation


Dysuria

Chocolate cyst

In endometriosis,Distorted,cystic ovaries filled with brown fluid due to previous haemorrhage

Adenomyosis

Presence of endometrial tissue within the uterine wall

Adenomyosis

Menometrorrhagia

Leiomyoma/Fibroids

Benign smooth muscle neoplasms of the uterus

Leiomyoma gross

Intramural


Submucosal


Subserosal

Leiomyoma microscopic

Whorled bundles of smooth muscle cells

Leiomyoma complications

Abnormal uterine bleeding


Urinary frequency


Impaired fertility


In pregnancy


Spontaneous abortion


Fetal malpresentation


PPH

Ovarian tumors classification

Surface epithelial stromal tumors


Sex cord stromal tumors


Germ cell tumors


Metastatic from other sites

Surface epithelial stromal tumors

Serous


Mucinous


Endometroid


Clear cell


Transitional cell (Brenner's)


Epithelial stromal (adenosarcoma,MMM)


SMECTE , benign borderline malignant

Sex cord stromal tumors

Granulosa tumors


Fibroma


thecoma


Thecoma


FibrothecomaThecomaSertoli-Leydig cell tumorsSteroid tumors


Sertoli-Leydig cell tumors


Steroid tumors

Germ cell tumors

Teratoma


Immature


Mature


Solid


Cystic


Monodermal


Dysgerminoma


Yolk sac tumors


Mixed germ cell tumors

Metastatic cancer from other sites

Colonic,appendiceal


Gastric


icobiliary


PancreaticobiliaryBreast


Breast


Hormone producing tumors of ovary

Granulosa theca cell- estrogen


Sertoli-Leydig cell - androgen


Choriocarcinoma - HCG

Causes of cystic mass in ovary

Follicular and luteal cysts


Polycystic ovary


Serous cystadenoma


Dermoid cyst

Polycystic ovaries

Hyperandrogenism


Menstrual abnormalities


Polycystic ovaries


Chronic anovulation


Decreased fertility

AMPAI

Polycystic ovaries

Stein Leventhal Syndrome

Polycystic ovaries Risk factors

Obesity


Type II DM


Premature atherosclerosis

Polycystic ovaries


Pathophysiology

Dysregulation of androgen biosynthesis


Excessive androgen production

Benign cystic teratoma

Germ cell tumors

Benign cystic teratoma

Opaque gray White epidermis


Hair shafts,tooth, calcification


Ovarian counterpart of seminoma of testis

Dysgerminoma of ovary

Dysgerminoma

Sheets and cords containing lymphocytes

Krukenberg tumors

Metastatic gastrointestinal neoplasms to the ovaries

Krukenberg tumors

Bilateral metastasis composed of mucin producing signet ring cancer cells

Meigs syndrome

Ovarian tumors+hydrothorax+ascitis


Fibrothecoma

Ovarian tumors markers

Epithelial-CA125,CA72-4,CA19-9,CEA


Germ cell - AFP,BETA HCG


Sex cord stromal - Estradiol,Inhibin